Pharm Block II - Corticosteroids Antiplatelets/Anticoagulants Flashcards
Outline hypothalamic-pituitary-adrenal feedback mechanisms for endogenous corticosteroid release
Hypothalmus releases corticotropin releasing factor (CRF) -> CRF acts on pituitary gland releasing corticotropin or ACTH -> these act on adrenal glands releasing aldosterone and cortisol (12-25mg/d) -> cortisol regulates the hypothalmus by negative feedback
Why give corticosteroids in the morning
The levels of cortisol are influenced by sleep cycle. Release peaks in the morning and have a stimulating effect. Exogenous corticosteroid is administered in attempts to mimic natural cycle and is giving in the morning to prevent insomnia.
2 types of corticosteroids
- glucocorticoids (act similar to cortisol, promotes gluconeogenesis)2. mineralcorticoids (similar to aldosterone)
Glucocorticoid MOA
Inhibits phosopholipase A2 decreases production of arachidonic acid inhibiting cyclooxgenase (reducing prostaglandins) and lipooxygenase (reducing leukotrienes)
Mineralocorticoids MOA
Acts on kidney tubules and collecting ducts to reabsorb Na, bicarb, water, and decreases reabsorption of K
physiologic dose of steroid
replacement or maintenance dose. The glucocorticoid dose administered to elicit the same effects as natural cortisol production in the body. mimics the diurnal pattern of normal secretion.
Oral steroid dosing - acute
Moderate to high dose for rapid resolution of symptoms (7-14 days, burst therapy)
Oral steroid dosing - acute
Minimum dose for shortest duration possible, morning dose preferred, sometimes POD
Oral steroid dosing - tapering principles
Less than 14 days with no prior exposure: rapid taper acceptable; long term exposure: slow taper mandatory; short term exposure to high dose with chronic use of low dose: rapid taper to chronic dose okay.
short term effects of glucocorticoids
hyperglycemia, elevated WBC count (due to demargination), GI bleed/ulcers, sodium retention (edema, hypertension CHF), hypokalemia, metabolic acidosis, steroid psychosis
long term effects of glucocorticoids
HPA axis suppression after 2 wks, cushingoid features, muscle weakness, thinning of skin, osteoporosis, cataracts/glaucoma, decreased immune response, poor wound healing
Anticoagulants: MOA
diminishes clotting factor actions; warfarin antagonizes cofactor funcitons of vitamin K resulting in production of clotting factors with diminished activity
anticoagulants prototype drug
warfarin (oral), heparin (IV)
antiplatelets MOA
inhibits production of thromboxane; aspirin inhibits COX-1 -> inhibiting thromboxane A2 synthesis from arachidonic acid in platelets resulting in suppression of platelet aggregation
antiplatelets prototype drug
aspirin